Medical Follow-up and Self-medication Among Medical Students

Medical Student Clinical Trial

— AutoMed-Int  

Official title:

Medical Follow-up and Self-medication Among Medical Students

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05578911
• Other study ID #: 2022_RIPH_005_AutoMed-Int
• Status: Completed
• Start date: October 5, 2022
• Est. completion date: November 7, 2022

Study information

• Verified date: October 2022
• Source: Université de Reims Champagne-Ardenne
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

As health actors, medical students educate patients to have regular medical follow-up and give them justified medical prescriptions. Regarding their own health, medical students do not seem to apply these same principles.

The medical follow-up of medical students seems insufficient, which can be explained by the lack of medical follow-up by occupational medicine, a consequent work time, but also the fear of judgment by colleagues Moreover, medical student have an easy access to all types of prescriptions and therefore the ease of self-prescription and self-medication. Medical students may also overestimate their medical knowledge and may not be objective about their symptomatology.

Description:

The aim of the study will be to describe medical follow-up and self-medication among medical students

Recruitment information / eligibility

• Status: Completed
• Enrollment: 264
• Est. completion date: November 7, 2022
• Est. primary completion date: November 7, 2022
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• medical student in general practice or in specialty medicine

• agreeing to participate in the study

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Medical Student

Intervention

Other:
• "medical students" group
medical student in general practice or in specialty medicine

Locations

Country	Name	City	State
France	Ufr Medecine Urca	Reims

Sponsors (1)

Lead Sponsor	Collaborator
Université de Reims Champagne-Ardenne

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	self-medication	Number of medical students with prescription for themself of a medical treatment	Day 0
Secondary	self-prescription	Number of medical students with prescription for themself of an biological analysis and/or a medical imaging	Day 0